Top Consumer Driven Health Care Stories
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
By Alan GoforthAs the drugmaker moves into Phase III studies for survodutide, its new GLP-1 obesity drug, Walgreens will use its community pharmacies as clinical trial sites, aiming to improve access and address equitable health representation.










